I’m not sure if it would help, maybe with financ
Post# of 148334
Look at all the big names that failed Pro 140. If not for CYDY, and especially NP, it would be shelved. When NP was asked about going it alone with sales, he said basically look at our accomplishments with leromlimab (comparing to those that failed I feel). I see why he has confidence, his team are finding results even the BP’s maraviroc team didn’t find. Fine said MT should be ‘pissed’ with the slow progress. Well, she was the one that failed Pro 140, she should be very greatful CYDY picked it up. Fine was complaining NP didn’t fine the 700mg dose earlier, and their phase 2 mono trial failed. Well again, the first team did the phase 1 dose escalation, if not for our new team, we would never have found the 700mg dose with great results.